Urinary excretion of cortisol, norepinephrine, testosterone, and melatonin in panic disorder

Pharmacopsychiatry

Volumn 30, Issue 4, 1997, Pages 113-117

  Bandelow, B ^a   Sengos, C ^a   Wedekind, D ^a   Huether, G ^a   Pilz, J ^a   Broocks, A ^a   Hajak, G ^a   Ruther E ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; MELATONIN; NORADRENALIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYDROCORTISONE URINE LEVEL; MALE; MEASUREMENT; PANIC; PRIORITY JOURNAL; STRESS; URINARY EXCRETION;

EID: 0030744529     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979494     Document Type: Article

References (47)

1. Abelson, J. L., G. C. Curtis: Hyothalamic-pituitary-adrenal axis activity in panic disorder - 24-hour secretion of corticotropin and cortisol. Arch. Gen. Psychiat. 53 (1996) 232-331
2. APA: American Psychiatric Association. DSM-IV - Diagnostic and statistical manual for mental disorders. Washington, DC, American Psychiatric Press 1994
3. Appleby, I., D. Klein, E. Sachar, M. Levitt: Biochemical indices of lactate-induced panik: a preliminary report. New York, Raven 1981
4. Bandelow, B.: The assessment of efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. Intern. Clin. Psychopharmacol. 10 (1995) 73-82
5. Brambilla F., L. Bellodi, G. Perna, M. Battaglia, G. Sciuto, G. Diaferia, F. Petraglia et al.: Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology 26 (1992) 12-22
6. Braune, S., M. Albus, M. Frohler, T. Hohn, G. Scheibe: Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal. Eur. Arch. Psychiatry Clin. Neurosci. 244 (1994) 86-92
7. Cameron, O. G., M. A. Lee, G. C. Curtis, D. S. McCann: Endocrine and physiological changes during "spontaneous" panic attacks. Psychoneuroendocrinology 12 (1987) 321-331
8. Cameron, O. G., R. M. Nesse: Systemic hormonal and physiological abnormalities in anxiety disorders. Psycnoneuroendocrinology 13 (1988) 287-307
9. Cameron, O. G., C. B. Smith, P. J. Hollingsworth, R. M. Nesse, G. C. Curtis: Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety. Arch. Gen. Psychiatry 41 (1984) 1144-1148
10. Cameron, O. G., C. B. Smith, M. A. Lee, P. J. Hollingsworth, E. M. Hill, G. C. Curtis: Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patiens and in normal subjects. Biol. Psychiatry 28 (1990) 3-20
11. Carr, D. B., D. V. Sheehan, O. S. Surman J. H. Coleman, D. J. Greenblatt, G. R. Heninger, K. J. Jones et al.: Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. Am. J. Psychiatry 143 (1986) 483-494
12. Charney, D. S., G. R. Heninger, P. I. Jatlow: Increased anxiogenic effects of caffeine in panic disorders. Arch. Gen. Psychiatry 42 (1985) 233-243
13. Charney D. S., S. W. Woods, W. K. Goodman, G. R. Heninger: Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am. J. Psychiatry 144 (1987) 1030-1036
14. Charney, D. S., S. W. Woods, W. K. Goodman, G. R. Heninger: Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology Berl. 92 (1987) 14-24
15. Dajas, F., A. Nin, L. Barbeito: Urinary norepinephrine excretion in panic and phobic disorders. J. Neural. Transm. 65 (1986) 75-81
16. Eriksson, E., P. Westberg, C. Alling, K. Thuresson, K. Modigh: Cerebrospinal fluid levels of monoamine metabolites in panic disorder. Psychiatry Res. 36 (1991) 243-251
17. Fraser, S., P. Lowen, M. Franklin, C. Franey, J. Arendt: Direct immunoassay for melatonin in plasma (letter). Clin. Chem. 29 (1983) 396-397
18. Goldstein, S., U. Halbreich, G. Asnis, J. Endicott, J. Alvir: The hypothalamic-pituitary-adrenal system in panic disorder. Am. J. Psychiatry 144 (1987) 1320-1323
19. Hajak, G., B. Bandelow: Angst und Schlafstörungen. München. Medizin Verlag 1992
20. Hamilton, M.: The assessment of anxiety States by rating. Br. J. Med. Psychol. 32 (1959) 50-55
21. Hellhammer, D.: Salivary Cortisol and behavior: an overview. Neuropsychobiology 22 (1989) 150-169
22. Hollander, E., M. R. Liebowitz, J. M. Gorman, B. Cohen, A. Fyer, D. F. Klein: Cortisol and sodium-lactate-induced panic. Arch. Gen. Psychiatry 46 (1989) 135-140
23. Kirschbaum, C., D. Hellhammer: Salivary cortisol and behavior: an overview. Neuropsychobiology 22 (1989) 150-169
24. Kuboki, T., H. Suematsu: [Panic disorder]. Nippon Rinsho 50 (1992) 2773-2782
25. Levin, A. P., A. R. Doran, M. R. Liebowitz, A. J. Fyer, J. M. Gorman, D. F. Klein, S. M. Paul: Pituitary adrenocortical unresponsiveness in lactate-induced panic. Psychiatry Res. 21 (1987) 23-32
26. Liebowitz, M. R., J. M. Gorman, A. J. Fyer, M. Levitt, D. Dillon. G. Levy, I. L. Appleby et al.: Lactate provocation of panic attacks. II. Biochemical and physiological findings. Arch. Gen. Psychiatry 42 (1985) 709-719
27. Lopez, A. L., R. G. Kathol, R. Noyes, Jr.: Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder. Psychoneuroendocrinology 15 (1990) 23-28
28. McCaul, K., B. Gladue, M. Joppa: Winning, losing, mood, and testosterone. Horm. Behav. 26 (1992) 486-504
29. McIntyre, I. M., F. K. Judd, G. D. Burrows, S. M. Armstrong, T. R. Norman: Plasma concentrations of melatonin in panic disorder. Am. J. Psychiatry 147 (1990) 462-464
30. McIntyre, I. M., P. F. Marriott, D. Jefferys, G. D. Burrows, F. K. Judd, T. R. Norman: Melatonin in panic disorder (letter). Biol. Psychiatry 21 (1986) 1438-1439
31. McIntyre, I. M., T. R. Norman, P. F. Marriott, G. D. Burrows: The pineal hormone melatonin in panic disorder. J. Affect. Disord. 12 (1987) 203-206
32. Nesse, R. M., O. G. Cameron, A. J. Buda, D. S. McCann, G. C. Curtis, M. J. Huber Smith: Urinary catecholamines and mitral valve prolapse in panic-anxiety patients. Psychiatry Res. 14 (1985) 67-75
33. Nesse, R. M., O. G. Cameron, G. C. Curtis, D. S. McCann, M. J. Huber Smith: Adrenergic function in patients with panic anxiety. Arch. Gen. Psychiatry 14 (1984) 771-776
34. NIMH: National Institute of Mental Health 028 CGI. Clinical Global Impressions. In: Guy, E.: ECDEU Assessment Manual for Psychopharmacology, Revised Edition, Rockville, Maryland (1976) 217-222
35. Pohl, R., E. Ettedgui, M. Bridges, H. Lycaki, D. Jimerson, I. Kopin, J. M. Rainey: Plasma MHPG levels in lactate and isoproterenol anxiety states. Biol. Psychiatry 22 (1987) 1127-1136
36. Rivier, C., S. Rivest: Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biol. Rerod. 45 (1991)
37. Robbins, J., J. Rall: The interaction of the thyroid hormone and protein in biological fluids. Rec. Progr. Horm. Res. 13 (1957) 161-208
38. Roy-Byrne, P. P., D. S. Cowley, D. Hammer, J. Ritchie, D. Greenblatt, C. Nemeroff: Neuroendocrine effects of diazepam in panic and generalized anxiety disorders. Biol. Psychiatry 30 (1991) 73-80
39. Roy-Byrne, P. P., W. Uhde, R. M. Post, W. Gallucci, G. P. Chrousos, P. W. Gold: The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am. J. Psychiatry 143 (1986) 896-899
40. Schneider, P., L. Evans, L. Ross Lee, B. Wiltshire, M. Eadie, J. Kenardy, H. Hoey: Plasma biogenic amine levels in agoraphobia with panic attacks. Pharmacopsychiatry 20 (1987) 102-104
41. Smedest, F., J. Kraak, H. Poppe: Simple and fast solvent extraction system for selectric and quantitative isolation of a adrenaline noradrenaline and dopamine from plasma and urine. J. Chromatogr. 231 (1982) 25-39
42. Targum, S. D.: Cortisol response during different anxiogenic challenges in panic disorder patients. Psychoneuroendocrinology 17 (1992) 453-458
43. Uhde, T. W., R. T. Joffe, D. C. Jimerson, R. M. Post: Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biol. Psychiatry 23 (1988) 575-585
44. Villacres, E. C., M. Hollifield, W. J. Katon, C. W. Wilkinson, R. C. Veith: Sympathetic nervous system activity in panic disorder. Psychiatry Res. 21 (1987) 313-321
45. WHO: World Health Organisation. Tenth Revision of the International Classification of Diseases, Chapter V (F): Mental and Behavioural Disorders (including disorders of psychological development). Clinical Descriptions and Diagnostic Guidelines. Geneva, World Health Organisation 1991
46. Woods, S. W., D. S. Charney, W. K. Goodman, G. R. Heninger: Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects. Arch. Gen. Psychiatry 45 (1988) 43-52
47. Yehuda, R., D. Boisoneau, J. W. Mason, E. L. Giller: Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol. Psychiatry 34 (1993) 18-25